Health Care Industry News
Side Effects | Are Doctors' Loyalties Divided?Physicians' disclosures to UW, journals inconsistent E-mail NewsletterMost Popular - News
Milwaukee Journal Sentinel | 6 minutes ago
Minesh Mehta: Didn't disclose his stock options or that he got the equivalent of $3,750 a day to consult for a radiation therapy company.... (more)
Latest Health Care Industry NewsMore >
Takeda, Amylin to co-develop obesity drugs
Yahoo! | 19 minutes ago
Readers ChoiceMore >
Amphastar-Momenta rivalry regarding generic heparin intensifies
FDLI SmartBrief | Nov 02, 2009
IVAX, Omnicare settle kickback allegations regarding Risperdal
FDLI SmartBrief | Nov 04, 2009
FDA program to curb medication errors
FDLI SmartBrief | Nov 05, 2009
FDA decides against Lipitor-Zetia combo
FDLI SmartBrief | Nov 03, 2009
FDA approves osteoarthritis drug from Nuvo Research
FDLI SmartBrief | Nov 06, 2009
FDLI News
More >
Speakers are confirmed for the Nov. 10 Tobacco Product Regulation conference!
FDLI SmartBrief | Nov 06, 2009
The all-inclusive desk reference guide, Food and Drug Law and Regulation
FDLI SmartBrief | Nov 06, 2009
Mark your 2010 calendar with FDLI program dates!
FDLI SmartBrief | Nov 05, 2009
Monograph Series
FDLI SmartBrief | Nov 05, 2009
Attend Introduction to Medical Device Law and Regulation to learn, refresh or update yourself on FDA regulations, including product approvals, labeling, promotion and general regulatory compliance issues, Nov. 17 and 18
FDLI SmartBrief | Nov 04, 2009
Latest Health Care Industry Press ReleasesMore >
Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care
PRNewswire | 13 hours 42 minutes ago
DX-88 (ecallantide) Demonstrated Relief of Symptoms in Hereditary Angioedema Acute Attacks in All Attack Locations
Business Wire | 13 hours 42 minutes ago
Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity
PRNewswire | 13 hours 42 minutes ago
GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010
Business Wire | 1 day 12 minutes ago
Celgene Corporation to Present at Two Upcoming Investor Conferences
Business Wire | 1 day 4 hours 11 minutes ago
Sign up for FDLI SmartBrief
Latest Blog Postsview more
Ants are friendly to some trees, but not others
Science Blog
AIBS publishes Darwin articles open access
Science Blog
Higher carotid arterial stenting rates associated with poorer clinical outcomes
Science Blog
AIBS publishes Darwin articles open access
Science Blog
Job Listingsview more
- Sr. Paralegal (Pharmaceutical Contracts/Transactions)
Endo Pharmaceuticals - Account Manager
Alfa Laval, Inc. - Health Policy Analyst and Programmer
Genentech - Advertising Associate Attorney
Manatt, Phelps & Phillips LLP - Manager, Commercial Compliance - Auditing
Amylin Pharmaceuticals
Companies in the news
- ARM Inc.
- Aetna Incorporated
- Amylin Pharmaceuticals Inc.
- CIGNA Corporation
- Exelixis Inc
- Genzyme
- GlaxoSmithKline plc
- Johnson & Johnson
Recent Poll view more polls